Core Scientific, Inc. Common Stock (CORZ) is a publicly traded Technology sector company. As of November 17, 2026, CORZ trades at $13.73 with a market cap of $4.68B and a P/E ratio of -18.68. CORZ moved +1.10% today. Year to date, CORZ is -14.98%; over the trailing twelve months it is -8.94%. Its 52-week range spans $6.20 to $30.46. Analyst consensus is strong buy with an average price target of $27.31. Rallies surfaces CORZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Core Scientific says capacity additions drive nearly 60% sequential Q3 colocation revenue growth: Core Scientific said third-quarter 2026 colocation revenue rose nearly 60% sequentially to $215 million, while adjusted EBITDA increased to $134 million from $41 million. Liquidity fell about $1 billion to $1.7 billion, and management expects double-digit sequential revenue growth in the fourth quarter.
| Metric | Value |
|---|---|
| Price | $13.73 |
| Market Cap | $4.68B |
| P/E Ratio | -18.68 |
| EPS | $-0.88 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.46 |
| 52-Week Low | $6.20 |
| Volume | 24.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $319.02M |
| Net Income | $-288.62M |
| Gross Margin | 11.88% |
13 analysts cover CORZ: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.31.